Skip to content

Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome

Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01312259
Enrollment
72
Registered
2011-03-10
Start date
2011-04-30
Completion date
2018-04-30
Last updated
2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Dysfunction, Interstitial Cystitis, Painful Bladder Syndrome, Pelvic Floor; Incompetency, Pelvic Floor; Insufficiency, Sexual Dysfunction

Keywords

Painful Bladder Syndrome, Interstitial Cystitis, Pelvic Floor dysfunction, Fecal incontinence, Constipation, Sexual dysfunction, Dyspareunia, Vulvodynia

Brief summary

Purpose: 1. To demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard). 2. The evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).

Detailed description

Purpose: 1. Primary: to demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard). 2. Secondary: The evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).

Interventions

OTHERChanging the Interstim parameter of '' Frequency in patients with Interstitial Cystitis

Subjects will be randomized into one of two groups. Group One will be programmed to receive 14 Hz as their frequency, while the other group (Group 2) will receive 40 Hz as their frequency for the first ninety days after surgical implantation. After three months each patient will come in to the office to have their InterStim frequency changed to the opposite frequency. After each patient has had three months to evaluate each of the two frequencies, the next step is to allow the patient to decide which setting they thought best controlled their respective symptoms. The InterStim was then programed to whichever frequency the patient chose, and this would remain for three to six months.

Sponsors

Pelvic and Sexual Health Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Female with diagnosis of IC/PBS with implanted IPG Interstim. * Scores \> 8 on the Interstitial Cystitis Symptom index questionnaire (ICSI) and \> 8 on the Interstitial Cystitis Problem Index questionnaire (ICPI). * Signed Informed Consent.

Exclusion criteria

* Progressive neurologic disease or peripheral neuropathy. * History of bladder surgery. * Subjects implanted with other neuromodulation device. * Current or planning pregnancy; Breastfeeding. * Subjects who are not deemed able to fill questionnaires * Mental illness or mentally unstable patients

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Urinary symptoms and Bladder pain/discomfort1 yearTo demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard).

Secondary

MeasureTime frameDescription
Improvement in Bowel symptoms and Sexual Function1 yearThe evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).

Countries

United States

Contacts

Primary ContactElizabeth Elias, CCRP
InterStimStudy@yahoo.com267 479 2387

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026